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T. Reina-Gutie´rrez,* F.J. Serrano-Hernando, L. Sa´nchez-Herva´s, A. Ponce,
M. Vega de Ceniga and A. Martı´nServicio de Angiologı´a y Cirugı´a Vascular, Hospital Clı´nico de Madrid, Madrid, SpainObjectives. To establish the incidence of restenosis (RES) following carotid endarterectomy (CEA) and evaluate clinical and
technical factors related to its development.
Design. Prospective non-randomised cohort study.
Patients and methods. Two hundred and twenty-four patients with 243 CEA between May 1998 and December 2002,
were subjected to clinical and haemodynamic follow-up, median follow-up 23 months (1–56). There was selective use of a
shunt (17.3%) and patch (61.7%). RES (R50%) and severe restenosis, R70%, (sRES) were defined as peak systolic
velocities ofR150 andR300 cm/s (orR250 cm/s with diastolic velocityO100 cm/s), respectively. Rates of RES, symptom
development and mortality were analysed using Kaplan–Meier curves. Cox’s regression model (hazards ratio/95% CI) was
used to evaluate prognostic factors.
Results. We detected 13 sRES (5.3%) (median time 6.1 months) and 30 (12.3%) moderate stenosis (mRES) (median time
3.7 months). Cumulative freedom from sRES at 23 months was 94.2%. Five sRES detected in the first 45 days after the
procedure were deemed to be residual restenosis (rRES). Five (38.4%) sRES were symptomatic, 15.3% progressed to
occlusion. Patient survival was 98.0 and 96.4% at 12 and 24 months, respectively. Independent risk factors for sRES: female
sex (HR: 3.3, 95% CI 1.1–10 pZ0.04) and diabetes (HR: 4.5, 95% CI 1.4–13.9 pZ0.008).
Conclusions. Carotid restenosis appears early, is usually low-grade and mostly asymptomatic. Although few stenoses
progress to occlusion, women and diabetic patients were at highest risk.Keywords: Recurrent carotid stenosis; Carotid endarterectomy; Riskfactors restenosis; Diabetes restenosis; Females
restenosis.Introduction
Carotid endarterectomy (CEA) has proved to be an
efficient procedure for the treatment of severe carotid
stenosis in both symptomatic and asymptomatic
patients.1,2 However, its ability to protect against
stroke may be affected by the appearance of restenosis
(RES) during follow-up. The capacity of a carotid RES
to cause a stroke seems to be highly variable, but in
general it is smaller than that of the primary lesion.3,4
The relative risk of stroke following RES ranges from
0.1 to 10, with a mean of 1.88.5
Since, the first description by Stoney and String in
1976,6 RES has been classified in two groups: RES
induced by intimal hyperplasia, usually of early onseting author. Dr Teresa Reina-Gutierrez, Servicio de
Cirugı´a Vascular, Hospital de Clinico de Madrid,
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0334+ 08 $35.00/0 q 2004 Published by Elsevier Ltd.and rarely producing symptoms and late RES caused
by recurrent arteriosclerotic disease, having the same
natural history as the original disease.3 Issues such as
prevention of RES, diagnosis, treatment and the ideal
time for treatment are still a matter of considerable
debate.
The use of a patch to close the arteriotomy or
eversion techniques have been shown to reduce the
incidence of RES,7,8 although not all patients benefit
from these procedures to the same degree. There is no
general consensus regarding the most appropriate
non-invasive follow-up protocol for the CEA.9–11 The
need for intra-operative assessment,12,13 the frequency
of surveillance,14,15 the interpretation of results16,17
and the subsequent management of any lesions
detected18–23 are all issues of constant debate and
ever changing ideas.
The present prospective study was designed to
determine the rates of carotid RES in a series of
patients consecutively undergoing CEA followed by aEur J Vasc Endovasc Surg 29, 334–341 (2005)
doi:10.1016/j.ejvs.2004.10.007, available online at http://www.sciencedirect.com on
Carotid Restenosis: Natural History 335strict, non-invasive follow-up program. Secondary
aims included the evaluation of the clinical course of
RES, with special attention to the presence of
symptoms, progression to carotid occlusion and the
identification of risk factors for RES.Materials and MethodsDesign: prospective non-randomised cohort study
We examined a cohort of 243 consecutive CEAs, in 224
patients, performed between May 1998 and December
2002 within a comprehensive clinical and non-invasive
follow-up program. We excluded patients who under-
went CEA combined with revascularisation of
supraortic trunks or coronary arteries. We also
excluded a further 14 procedures because we lacked
follow-up data: one patient died in the postoperative
period; one patient suffered a stroke due to early
thrombosis of the operated carotid artery in the
presence of a contralateral occlusion; two patients
died before the first follow-up session, one after
surgery to replace an aortic valve and the other
because of a perforated diverticulitis; five patients
had not attended their first follow up; and the
remaining five patients were lost to follow-up.
Follow-up was, therefore, complete in 94.5% of the
series.Surgical protocol: local anaesthesia was used in 90.9% of the
patients
Antiplatelet drugs were maintained on all the patients
until the day of surgery. Also, an infusion of dextran
was routinely begun while the arteriotomy is being
closed, and continued during the first 24 h. Later,
antiplatelet medication life-long was recommended.
We used anticoagulation during carotid clamping, but
this was reversed when arterial flow was re-estab-
lished. A shunt or patch was used selectively. The
selection criterion for shunt was the onset of signs of
cerebral ischaemia during clamping of the carotid
artery when local anaesthesia was used. Routine
shunting was used in patients operated on under
general anaesthesia. A patch to close the arteriotomy
was indicated when the diameter of the internal
carotid artery was!4 mm, if lesions extended widely
beyond the carotid bulb and in patients operated on
for restenosis. We used a prosthetic patch in all the
cases (collagen-coated polyester vascular patch Inter-
vascularw). A shunt was used in 17.9% and a patch in
61.5% of the cases.Follow-up protocol
In May 1998, a Duplex scanning follow-up protocol
was established to target all patients undergoing
endarterectomy of the carotid bifurcation. A clinical
assessment and colour Duplex-scanning of both
carotid bifurcations was performed in the third and
sixth months following the surgical procedure and
every 6 months thereafter. The frequency of these
examinations was modified if progressing or severe
lesions were detected, or if patients showed symptoms
of cerebral ischaemia. All Duplex-scans were per-
formed by the same technician using the HDI 3000
colour Duplex-scan (Advanced Technology Labora-
tories Bothell, USA) and a 4–7 MHz linear probe. The
peak systolic velocity (PSV) and end-diastolic velocity
(EDV) were measured in the common, internal and
external carotid arteries bilaterally and measurements
recorded prospectively in a Microsoft Access data-
base.
We defined stroke as the appearance of a neuro-
logical deficit during the follow-up, lasting more than
24 h, which caused some kind of permanent damage.
The findings were confirmed by a clinical neurologist.Haemodynamic criteria for restenosis
Restenosis was defined by a PSV recorded in the
surgically treated carotid artery O150 cm/s, corre-
sponding to a stenosis O50% according to the
NASCET criteria; severe RES (sRES) was defined by
a PSV O300 cm/s, or PSV O250 cm/s and EDV O
100 cm/s, corresponding to a stenosis R70% accord-
ing to the NASCET criteria. The ultrasound diagnosis
of sRES was confirmed by arteriography or magnetic
resonance angiography. Using these velocity criteria,
the correlation Kappa index between Duplex-scan and
arteriography for the diagnosis of a severe stenosis
was 0.8.Criteria for residual stenosis
Stenosis detected within the first 45 days (randomly
selected cut-off) was considered as residual restenosis
(rRES).
Lesions were considered true RES if they persisted
in at least two consecutive Duplex-scans, they were
sub-occlusive or symptomatic, regardless of whether
these lesions has progressed from a rRES or whether
they were of late appearance. Survival was analysed
by the Kaplan–Meier method, and we estimated the
rates of overall RES, sRES and neurological symptoms.
We also evaluated the possible effects on theEur J Vasc Endovasc Surg Vol 29, April 2005
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clinical characteristics of the patients including age,
sex, hypertension, diabetes mellitus, smoking, hyper-
lipidaemia, preoperative symptoms and technical
details such as the use of a shunt and the type of
arteriotomy closure. We evaluated the presence of
rRES at the first postoperative examination and its
possible effect on the development of true RES. For this
analysis, we used the Breslow test and the Cox
regression model, calculating the hazard ratio (HR)
for each factor and its 95% confidence interval. The
level of significance was set at p!0.05.ResultsDescriptive analysis
The mean age of the 242 patients was 70.6 (SE: 2.7)
years and 78,2% were male. Comorbidities included
hypertension (68%), diabetes mellitus (29.2%), hyper-
lipidaemia (45.9%), smoking (72.4%), ischaemic heart
disease (31.6%), previous coronary angioplasty or
bypass (13.7%). 41.6% of the procedures were per-
formed on asymptomatic patients, and 10.9% had a
contra-lateral carotid occlusion. The median time (MT)
of follow-up was 23 months.
Early results
One patient died after suffering an intraoperative
stroke under general anaesthesia, giving a peri-
operative mortality of 0.4%. The incidence of stroke
with permanent residual deficit was 1.2%. Three
patients suffered an ischaemic stoke ipsilateral to the
surgically treated carotid artery, two of whom suffered
mild permanent deficits.
Late results
The late mortality rate during follow-up was 0.8%.
One patient suffered a myocardial infarction and died
4 months after the procedure, and another patient
suffered a cardiac arrest in at home 13.4 months after
surgery.
Restenosis
We detected 64 lesions with haemodynamic criteria of
RES at some point during the follow-up, 21 of which
(31.2%) were not confirmed in subsequent evaluations.
Forty-three arteries (17.6%) developed true RES
according to the criteria described above. The inci-
dence of severe RES and moderate RES (mRES) were
5.3% (13 cases) and 12.3% (30 cases), respectively.
46.1% of sRES appeared after a previous normal followEur J Vasc Endovasc Surg Vol 29, April 2005up examination. 15.3% of these sRES progressed to
occlusion and 38.4% were symptomatic.Residual lesions
The first scan was performed within the first 45 days
after surgery (MT 32 days) on 83 patients (34.2% of all
cases): 45 days was the cut-off point for definition of
rRES. At this early examination, 10 stenoses (2.4%)
were detected. Half of these lesions showed haemo-
dynamic criteria of severe restenosis, but in three of
these only moderate restenosis was detected at the
subsequent Duplex-scan. One of the two remaining
severe stenoses was corrected surgically and the other
occluded in less than 1a month. The five moderate
rRES were asymptomatic; three improved and the
other two remained stable during the rest of follow-up.
None of these moderate rRES progressed to severe
stenosis or occlusion.Symptoms of restenosis
Only five RES (11.3% of the total) were symptomatic.
In each case, the clinical picture was transient with no
permanent neurological sequelae. These five sympto-
matic restenosis were severe lesions.Treatment of restenosis
Ten severe RES out of the 13 diagnosed (76.9%) were
treated: five by stent angioplasty and five by conven-
tional surgery, with no morbidity or mortality in either
group, except for a single peripheral nerve lesion in
one patients treated surgically. Half of them were
treated because they were symptomatic and the other
half because the stenoses were critical or rapidly
progressive. None of the treated restenotic lesions
suffered further secondary restenosis during follow
up.Carotid occlusion
Two of the non-treated severe RES arteries occluded in
less than a month after having been diagnosed due to
rapid progression (one of them a progression of a
severe residual lesion). In both these cases, the carotid
occlusion was asymptomatic.Survival analysis
The Kaplan–Meier (KM) analysis indicated overall
survival rates of 98 and 96.4% at 12 and 23 months (MT
of follow-up).
The Kaplan–Meier curve of RES-free rates indicated
that 93.7, 88.4, 81.4, 80.8 and 80.2% of the arteries
operated on were RES-free at 3, 6, 12, 18 and 24
Fig. 1. Kaplan–Meier curve for the incidence of restenosis.
Carotid Restenosis: Natural History 337months, respectively. 93% of RES occurred during the
first year of follow-up (Fig. 1).
The Kaplan–Meier curve of severe RES-free rates
indicated that 99.1, 97.3, 94.2 and 94.2% of the repaired
arteries were sRES-free at 3, 6, 12 and 24months. 92.3%
of severe RES occurred during the first year of follow-
up (Fig. 2).
The Kaplan–Meier curve of patients free fromFig. 2. Kaplan–Meier curve for the incidence of severe
restenosis.neurological signs, ipsilateral to the operated carotid
artery, indicated that 99.6, 99.1, 98 and 98% were
asymptomatic at 3, 6, 12 and 24 months, respectively,
with a SE at 23 months of 1%.Prognostic factors
Overall restenosis (RES)
In univariate analysis, factors related to the appear-
ance of RES were: female sex (27.8 versus 14.8%; pZ
0.04) and the presence of a residual RES (80.9 versus
15%; pZ0.001), Fig. 3. Multivariate analysis revealed
female sex (HR 2.5, 95% CI 1.2–5; pZ0.01) and the
presence of rRES (HR 18.2, 95% CI 6.2–53; pZ0.001) as
independent risk factors.
Severe restenosis (sRES)
In univariate analysis, factors associated with the
development of severe RES were female sex (11.1
versus 3.7%, HR 3 95% CI 1.1–10, pZ0.04), diabetes
mellitus (11.6 versus 2.9%, HR 4.54 95% CI 1.4–13.9,
pZ0.008) and rRES (20 versus 4.7%, 95% CI 1.2–18.9,
pZ0.007), Fig. 4.
Cox’s multivariate regression confirmed only
female sex (HR 2, 95% CI 1.1–3.3) and diabetes
mellitus (HR 6.1, 95% CI 1.9–19.5) as independent
risk factors for sRES. The presence of a residual
stenosis was of borderline significance (HR 5.2, 95% CI
1.2–26; pZ0.06).
Neurological symptoms
In the analysis of factors associated with the appear-
ance of symptoms during follow-up, only the presence
of severe RES in the surgically treated carotid artery
was identified as a predictive factor (38.5 versus 0%;
p!0.0001) (HR undetermined).Discussion
Our study indicates that restenosis usually arises early
on after surgery and is generally low-grade and rarely
symptomatic. Although infrequent, severe restenosis
showed an unpredictable behaviour. Almost half
appeared suddenly, following a previously normal
Duplex-scan, 40% of these severe lesions were symp-
tomatic and 15.3% rapidly progressed to occlusion.
Women and patients with diabetes were identified as
subsets of patients at particular risk of developing
both RES and severe RES. Whilst residual restenosis
was a risk factor for developing overall RES, any
independent association with severe restenosis was
not proven.Eur J Vasc Endovasc Surg Vol 29, April 2005
Fig. 3. Univariate analysis of factors associated with restenosis. The numbers in the right hand column show the percentage
having this risk factor as a total of those with and without restenosis, followed by the significance of the finding.
T. Reina-Gutie´rrez et al.338The haemodynamic criteria used to define RES
were those developed by the University ofWashington
and modified by Moneta et al. in 1993.16 These authors
related greatest diagnostic reliability, according to the
NASCET criteria, to a PSV O300 cm/s (88%
reliability), EDV O100 cm/s (85% reliability) and a
systolic velocity ratio ICA/CCA (internal carotid
artery/common carotid artery) of 4 (88% reliability).
In our study, all the Duplex-scans were performed by
the same operator, using the same Duplex-scanner, on 
 
 
Fig. 4. Univariate analysis of factors associated with severe
percentage having this risk factor as a total of those with and
Eur J Vasc Endovasc Surg Vol 29, April 2005all the patients. On some occasions, more than one
haemodynamic criterion was applied, since this has
been shown to improve reliability.17 The systolic
velocity ICA/CCA ratio was used as a complementary
criterion in patients with bilateral carotid disease,
since severe stenosis or occlusion of the contralateral
carotid artery can overestimate the lesions detected.22
It is well established that many lesions detected at
the first postoperative examination, especially when
performed very early on, disappear in following 
restenosis. The left hand column of figures indicates the
without restenosis.
Carotid Restenosis: Natural History 339Duplex-scans.11,12 We observed this in our study,
where 31.2% of the patients with haemodynamic
criteria of restenosis at the first follow-up had a
normal Duplex-scan at subsequent follow-up. In our
study, the findings of this first scan determined, in
some cases, the subsequent follow-up frequency.
Patients showing a normal first revision were included
in the standard follow-up programme, while those
showing an anomaly were examined again 30 days
later in order to detect any rapidly progressive
restenosis. Nevertheless, two diagnosed severe rest-
enoses progressed to occlusion in less than a month.
The follow-up program was completed in all the
patients regardless of the findings at first follow
up. Some authors have observed that recurrent
stenosis, with worst prognosis, develops mostly
between the third and the sixth months of follow-
up, often independent of the findings of the first
postoperative examination.4,24 In our series almost
half of the severe restenosis had a previously
normal Duplex-scan.
The capacity of a restenosis to cause a stroke has
been associated with the occlusion of the carotid
artery18,25 and with the late-onset of the restenosis.3,5
In our series, most severe RES, symptomatic or not,
were treated. Two of the three non-treated RES became
occluded, but they both remained asymptomatic. Our
aggressive approach towards the treatment of severe
restenosis has prevented us from observing the natural
history of these severe lesions. Naylor et al.26 recently
published a series of patients with restenosis who
were managed conservatively, and they reported a
10% incidence of stroke. This is similar to our findings.
The rates of recurrent stenosis following carotid
endarterectomy in the various published series range
from 1 to 36%,3,4,9,10,11,13,14,23,25,27,28 with varied follow-
up protocols. There is little argument, however,
concerning the early appearance of these lesions and
the low incidence of neurological symptoms they
cause. A systematic review by Frericks et al. in 19985
concluded that the risk of restenosis after CEA was
10% in the first year, 3% in the second year and only
1% per year thereafter. The risk of stroke arising from a
restenosis, although low, was highly variable, ranging
from 0.1 to 10.
The follow-up results for patients included in the
(ACAS) asymptomatic carotid artery stenosis study3
indicated the total risk of restenosis (O60% diameter
reduction) including residual and early and late
restenosis ranged from 13.6 to 21%, depending on
the participating centre. The incidence of stroke
during follow-up was extremely low. Patients with
restenosis showed a greater incidence of symptoms,
though the difference was not significant.There is general agreement that low-grade rest-
enosis has a benign course, rarely progressive, does
not cause symptoms and often regresses.3–5,11–13 In our
series, no low-grade restenosis became occluded or
symptomatic. Similarly, a high percentage (31.2%) of
moderate lesions detected in the first follow-up
Duplex-scan regressed in following controls. It is an
established fact that in the first month after surgery it
is common to find haemodynamic disturbances,
which were not present intra-operatively, but later
disappear. These are probably related to the post-
operative inflammatory response at the site of the
endarterectomy.4,12,29
Severe restenosis constitutes the real problem, since
progression to occlusion is fairly common. The risk of
stroke from a carotid occlusion in patients not under
anticoagulation treatment can be as high as 25%, and the
risk of stroke fromanobstructed carotid artery can reach
10%.30 The prevention of carotid occlusion is, therefore,
one of the aims of treating carotid restenosis.18,25
Several authors have identified women as a high-
risk group for the development of restenosis,4,9,24,31,32
with no clear explanation of why this is so. Hormonal
causes have been suggested,33 although most authors
describe artery size and kinking to be the most
significant factors.
In our series, diabetes mellitus was associated with
the development of severe restenosis. Diabetic patients
were those who most frequently presented with
restenosis, which rapidly progressed to severity or
even occlusion, after an initial normal follow-up
examination. Diabetes mellitus is an independent
risk factor for arteriosclerosis34 and has been linked
to worse CEA outcomes,35,36 and a higher incidence of
intimal hyperplasia.37 Several studies have shown that
the final products of advanced glycolysis with
enhanced proliferation, adhesion and migration of
muscle cells in the vessel wall, which clearly is related
to intimal hyperplasia restenosis.38
Residual stenosis has been considered by some
authors to be one of the main causes of restenosis.
Pross et al.39 did not find any severe restenosis in the
first 6 months after CEA with normal intraoperative
scans. Carballo et al.25 described significant differences
associated with the appearance of restenosis among
patients showing a normal intraoperative scan and
those with residual stenosis. In the present series, these
residual lesions predicted the appearance of restenosis,
but no clear association with severe restenosis,
neurological symptoms, carotid occlusion or mortality
was demonstrated. Our inability to demonstrate these
associations may result from the an insufficient sample
size, since both residual and severe restenosis were
rare.Eur J Vasc Endovasc Surg Vol 29, April 2005
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Carotid endarterectomy has a low incidence of
neurological symptoms and death due to stroke
during follow-up. Most recurrent stenoses appear
early on after surgery and are moderate and asympto-
matic. Severe restenosis is uncommon, shows a peak
incidence between the third and sixth month after
surgery and can quickly progress to occlusion. Women
and diabetic patients are at increased risk of severe
restenosis.References
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